BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32201914)

  • 1. Spinal cord hypermetabolism extends to skeletal muscle in amyotrophic lateral sclerosis: a computational approach to [18F]-fluorodeoxyglucose PET/CT images.
    Bauckneht M; Lai R; Miceli A; Schenone D; Cossu V; Donegani MI; Raffa S; Borra A; Marra S; Campi C; Orengo A; Massone AM; Tagliafico A; Caponnetto C; Cabona C; Cistaro A; Chiò A; Morbelli S; Nobili F; Sambuceti G; Piana M; Marini C
    EJNMMI Res; 2020 Mar; 10(1):23. PubMed ID: 32201914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis.
    Marini C; Cistaro A; Campi C; Calvo A; Caponnetto C; Nobili FM; Fania P; Beltrametti MC; Moglia C; Novi G; Buschiazzo A; Perasso A; Canosa A; Scialò C; Pomposelli E; Massone AM; Bagnara MC; Cammarosano S; Bruzzi P; Morbelli S; Sambuceti G; Mancardi G; Piana M; Chiò A
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2061-71. PubMed ID: 27421971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain Stem Glucose Hypermetabolism in Amyotrophic Lateral Sclerosis/Frontotemporal Dementia and Shortened Survival: An
    Zanovello M; Sorarù G; Campi C; Anglani M; Spimpolo A; Berti S; Bussè C; Mozzetta S; Cagnin A; Cecchin D
    J Nucl Med; 2022 May; 63(5):777-784. PubMed ID: 34503963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective Validation of 18F-FDG Brain PET Discriminant Analysis Methods in the Diagnosis of Amyotrophic Lateral Sclerosis.
    Van Weehaeghe D; Ceccarini J; Delva A; Robberecht W; Van Damme P; Van Laere K
    J Nucl Med; 2016 Aug; 57(8):1238-43. PubMed ID: 26940764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined brain and spinal FDG PET allows differentiation between ALS and ALS mimics.
    Van Weehaeghe D; Devrome M; Schramm G; De Vocht J; Deckers W; Baete K; Van Damme P; Koole M; Van Laere K
    Eur J Nucl Med Mol Imaging; 2020 Oct; 47(11):2681-2690. PubMed ID: 32314027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing the diagnostic accuracy of [18F]FDG-PET in discriminating spinal- and bulbar-onset amyotrophic lateral sclerosis.
    Sala A; Iaccarino L; Fania P; Vanoli EG; Fallanca F; Pagnini C; Cerami C; Calvo A; Canosa A; Pagani M; Chiò A; Cistaro A; Perani D
    Eur J Nucl Med Mol Imaging; 2019 May; 46(5):1117-1131. PubMed ID: 30617963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis.
    Pagani M; Chiò A; Valentini MC; Öberg J; Nobili F; Calvo A; Moglia C; Bertuzzo D; Morbelli S; De Carli F; Fania P; Cistaro A
    Neurology; 2014 Sep; 83(12):1067-74. PubMed ID: 25122207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
    Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
    J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between spinal cord and cerebral cortex metabolism in amyotrophic lateral sclerosis.
    Marini C; Morbelli S; Cistaro A; Campi C; Caponnetto C; Bauckneht M; Bellini A; Buschiazzo A; Calamia I; Beltrametti MC; Margotti S; Fania P; Poggi I; Cabona C; Capitanio S; Piva R; Calvo A; Moglia C; Canosa A; Massone A; Nobili F; Mancardi G; Chiò A; Piana M; Sambuceti G
    Brain; 2018 Aug; 141(8):2272-2279. PubMed ID: 30730551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [(18)F]FDG-PET/CT metabolic parameters as useful prognostic factors in cervical cancer patients treated with chemo-radiotherapy.
    Herrera FG; Breuneval T; Prior JO; Bourhis J; Ozsahin M
    Radiat Oncol; 2016 Mar; 11():43. PubMed ID: 26984385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of SUV, tumor-to-blood standard uptake ratio (SUR), and dual time point measurements for assessment of the metabolic uptake rate in FDG PET.
    Hofheinz F; Hoff Jv; Steffen IG; Lougovski A; Ego K; Amthauer H; Apostolova I
    EJNMMI Res; 2016 Dec; 6(1):53. PubMed ID: 27334609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
    Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms underlying the predictive power of high skeletal muscle uptake of FDG in amyotrophic lateral sclerosis.
    Marini C; Cossu V; Bonifacino T; Bauckneht M; Torazza C; Bruno S; Castellani P; Ravera S; Milanese M; Venturi C; Carlone S; Piccioli P; Emionite L; Morbelli S; Orengo AM; Donegani MI; Miceli A; Raffa S; Marra S; Signori A; Cortese K; Grillo F; Fiocca R; Bonanno G; Sambuceti G
    EJNMMI Res; 2020 Jul; 10(1):76. PubMed ID: 32638178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-FDG-PET correlates of cognitive impairment in ALS.
    Canosa A; Pagani M; Cistaro A; Montuschi A; Iazzolino B; Fania P; Cammarosano S; Ilardi A; Moglia C; Calvo A; Chiò A
    Neurology; 2016 Jan; 86(1):44-9. PubMed ID: 26590270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter validation of [
    D'hulst L; Van Weehaeghe D; Chiò A; Calvo A; Moglia C; Canosa A; Cistaro A; Willekens SM; De Vocht J; Van Damme P; Pagani M; Van Laere K
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Nov; 19(7-8):570-577. PubMed ID: 29862846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT.
    Cohade C; Osman M; Pannu HK; Wahl RL
    J Nucl Med; 2003 Feb; 44(2):170-6. PubMed ID: 12571205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of 18f-fluorodeoxyglucose positron emission tomography-computed tomography in predicting survival in patients with unresectable metastatic melanoma to the liver undergoing yttrium-90 radioembolization.
    Piduru SM; Schuster DM; Barron BJ; Dhanasekaran R; Lawson DH; Kim HS
    J Vasc Interv Radiol; 2012 Jul; 23(7):943-8. PubMed ID: 22609292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-FDG PET/CT for Early Postradiotherapy Assessment in Solitary Bone Plasmacytomas.
    Alongi P; Zanoni L; Incerti E; Fallanca F; Mapelli P; Papathanasiou N; Gianolli L; Picchio M; Bomanji J
    Clin Nucl Med; 2015 Aug; 40(8):e399-404. PubMed ID: 26018693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in Burkitt lymphoma.
    Albano D; Bosio G; Pagani C; Re A; Tucci A; Giubbini R; Bertagna F
    Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):87-96. PubMed ID: 30276438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer.
    Higashi K; Ueda Y; Arisaka Y; Sakuma T; Nambu Y; Oguchi M; Seki H; Taki S; Tonami H; Yamamoto I
    J Nucl Med; 2002 Jan; 43(1):39-45. PubMed ID: 11801701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.